| |
| |
|
| Insider
Information: |
Delong Mark Jeffrey |
| Relationship: |
Chief Business & Strat... |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
54,693 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,259,368 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
54,693 |
|
|
| Total
Value |
$2,259,368 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Business & Strat... |
2024-03-18 |
54,693 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice PresidentOfficer |
• – – |
2021-03-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,698 |
|
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-05-18 |
4 |
OE |
$15.52 |
$31,040 |
D/D |
2,000 |
11,490 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-05-18 |
4 |
AS |
$55.00 |
$110,000 |
D/D |
(2,000) |
9,490 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-07-15 |
4 |
OE |
$15.52 |
$15,520 |
D/D |
1,000 |
10,490 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-07-15 |
4 |
AS |
$62.30 |
$62,300 |
D/D |
(1,000) |
9,490 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-07-21 |
4 |
AS |
$65.00 |
$65,000 |
D/D |
(1,000) |
9,490 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-07-21 |
4 |
OE |
$15.52 |
$15,520 |
D/D |
1,000 |
10,490 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2021-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
882 |
10,372 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,592 |
20,964 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• – – |
2022-01-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
13,913 |
24,285 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-01-28 |
4 |
D |
$38.59 |
$16,748 |
D/D |
(434) |
20,530 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,901 |
28,481 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-02-10 |
4 |
D |
$47.12 |
$12,770 |
D/D |
(271) |
23,580 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-04-20 |
4 |
OE |
$15.52 |
$108,640 |
D/D |
7,000 |
35,481 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-04-20 |
4 |
AS |
$52.53 |
$367,710 |
D/D |
(7,000) |
28,481 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-06-16 |
4 |
OE |
$13.85 |
$138,500 |
D/D |
10,000 |
39,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-06-16 |
4 |
S |
$41.79 |
$417,850 |
D/D |
(10,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-19 |
4 |
AS |
$56.42 |
$282,100 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-19 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-27 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-27 |
4 |
AS |
$57.00 |
$285,000 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-04 |
4 |
AS |
$59.50 |
$607,500 |
D/D |
(10,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-04 |
4 |
OE |
$15.52 |
$155,200 |
D/D |
10,000 |
39,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-08 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-08 |
4 |
AS |
$64.50 |
$322,500 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
